Search research articles
Contact Us
Filters
Showing results (31-40 of 40) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 40 results.
Journal of Cardiovascular Pharmacology
|
April 5, 2012
Endogenous glucocorticoids inhibit myocardial inflammation induced by lipopolysaccharide: involvement of regulation of histone deacetylation
Hai-Ning Zhang, Yan-Hua He, Gen-Shui Zhang, et al.
Stem Cells International
|
January 20, 2016
Impact of Timing following Acute Myocardial Infarction on Efficacy and Safety of Bone Marrow Stem Cells Therapy: A Network Meta-Analysis
Bei Liu, Chong-Yang Duan, Cheng-Feng Luo, et al.
Journal of Cardiovascular Pharmacology
|
May 31, 2013
MicroRNA-26 was decreased in rat cardiac hypertrophy model and may be a promising therapeutic target
Zhen-hui Zhang, Jiao Li, Ben-rong Liu, et al.
Molecular and Cellular Biochemistry
|
January 12, 2010
Co-culture with cardiomyocytes enhanced the myogenic conversion of mesenchymal stromal cells in a dose-dependent manner
Xiao-Qing He, Min-Sheng Chen, Shu-Hong Li, et al.
International Journal of Cardiology
|
December 4, 2014
Effectiveness and safety of selected bone marrow stem cells on left ventricular function in patients with acute myocardial infarction: a meta-analysis of randomized controlled trials
Bei Liu, Chong-Yang Duan, Cheng-Feng Luo, et al.
Cardiovascular Research
|
June 30, 2012
Impaired sonic hedgehog pathway contributes to cardiac dysfunction in type 1 diabetic mice with myocardial infarction
Qing Xiao, Ning Hou, Yan-Ping Wang, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology
|
February 18, 2017
Puerarin-7-O-glucuronide, a water-soluble puerarin metabolite, prevents angiotensin II-induced cardiomyocyte hypertrophy by reducing oxidative stress
Ning Hou, Bin Cai, Cai-Wen Ou, et al.
Frontiers in Pharmacology
|
June 22, 2018
Nrf2 Is a Key Regulator on Puerarin Preventing Cardiac Fibrosis and Upregulating Metabolic Enzymes UGT1A1 in Rats
Shao-Ai Cai, Ning Hou, Gan-Jian Zhao, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
June 28, 2018
Contributions of Nrf2 to Puerarin Prevention of Cardiac Hypertrophy and its Metabolic Enzymes Expression in Rats
Gan-Jian Zhao, Ning Hou, Shao-Ai Cai, et al.
Acta Pharmacologica Sinica
|
June 7, 2020
Puerarin ameliorated pressure overload-induced cardiac hypertrophy in ovariectomized rats through activation of the PPARα/PGC-1 pathway
Ning Hou, Yin Huang, Shao-Ai Cai, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 40) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 40 results.
Journal of Cardiovascular Pharmacology
|
April 5, 2012
Endogenous glucocorticoids inhibit myocardial inflammation induced by lipopolysaccharide: involvement of regulation of histone deacetylation
Hai-Ning Zhang, Yan-Hua He, Gen-Shui Zhang, et al.
Stem Cells International
|
January 20, 2016
Impact of Timing following Acute Myocardial Infarction on Efficacy and Safety of Bone Marrow Stem Cells Therapy: A Network Meta-Analysis
Bei Liu, Chong-Yang Duan, Cheng-Feng Luo, et al.
Journal of Cardiovascular Pharmacology
|
May 31, 2013
MicroRNA-26 was decreased in rat cardiac hypertrophy model and may be a promising therapeutic target
Zhen-hui Zhang, Jiao Li, Ben-rong Liu, et al.
Molecular and Cellular Biochemistry
|
January 12, 2010
Co-culture with cardiomyocytes enhanced the myogenic conversion of mesenchymal stromal cells in a dose-dependent manner
Xiao-Qing He, Min-Sheng Chen, Shu-Hong Li, et al.
International Journal of Cardiology
|
December 4, 2014
Effectiveness and safety of selected bone marrow stem cells on left ventricular function in patients with acute myocardial infarction: a meta-analysis of randomized controlled trials
Bei Liu, Chong-Yang Duan, Cheng-Feng Luo, et al.
Cardiovascular Research
|
June 30, 2012
Impaired sonic hedgehog pathway contributes to cardiac dysfunction in type 1 diabetic mice with myocardial infarction
Qing Xiao, Ning Hou, Yan-Ping Wang, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology
|
February 18, 2017
Puerarin-7-O-glucuronide, a water-soluble puerarin metabolite, prevents angiotensin II-induced cardiomyocyte hypertrophy by reducing oxidative stress
Ning Hou, Bin Cai, Cai-Wen Ou, et al.
Frontiers in Pharmacology
|
June 22, 2018
Nrf2 Is a Key Regulator on Puerarin Preventing Cardiac Fibrosis and Upregulating Metabolic Enzymes UGT1A1 in Rats
Shao-Ai Cai, Ning Hou, Gan-Jian Zhao, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
June 28, 2018
Contributions of Nrf2 to Puerarin Prevention of Cardiac Hypertrophy and its Metabolic Enzymes Expression in Rats
Gan-Jian Zhao, Ning Hou, Shao-Ai Cai, et al.
Acta Pharmacologica Sinica
|
June 7, 2020
Puerarin ameliorated pressure overload-induced cardiac hypertrophy in ovariectomized rats through activation of the PPARα/PGC-1 pathway
Ning Hou, Yin Huang, Shao-Ai Cai, et al.
Page
of 4